AT355743B - Verfahren zur herstellung von neuen kortikoiden - Google Patents

Verfahren zur herstellung von neuen kortikoiden

Info

Publication number
AT355743B
AT355743B AT504777A AT504777A AT355743B AT 355743 B AT355743 B AT 355743B AT 504777 A AT504777 A AT 504777A AT 504777 A AT504777 A AT 504777A AT 355743 B AT355743 B AT 355743B
Authority
AT
Austria
Prior art keywords
producing new
new corticoids
corticoids
producing
new
Prior art date
Application number
AT504777A
Other languages
German (de)
English (en)
Other versions
ATA504777A (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA504777A publication Critical patent/ATA504777A/de
Application granted granted Critical
Publication of AT355743B publication Critical patent/AT355743B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT504777A 1976-07-16 1977-07-13 Verfahren zur herstellung von neuen kortikoiden AT355743B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2632678A DE2632678C2 (de) 1976-07-16 1976-07-16 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
ATA504777A ATA504777A (de) 1979-08-15
AT355743B true AT355743B (de) 1980-03-25

Family

ID=5983515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT504777A AT355743B (de) 1976-07-16 1977-07-13 Verfahren zur herstellung von neuen kortikoiden

Country Status (11)

Country Link
JP (1) JPS5315361A (enExample)
AT (1) AT355743B (enExample)
BE (1) BE856862A (enExample)
CH (1) CH627191A5 (enExample)
DE (1) DE2632678C2 (enExample)
DK (1) DK323877A (enExample)
FR (1) FR2358421A1 (enExample)
GB (1) GB1589585A (enExample)
IT (1) IT1125789B (enExample)
LU (1) LU77768A1 (enExample)
NL (1) NL7707920A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2244000B (en) * 1990-05-18 1993-09-22 Teasdale S Mattress
MX2012010824A (es) 2010-03-26 2012-10-10 Galderma Res & Dev Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema.
EP2768502A2 (en) 2011-10-19 2014-08-27 Galderma S.A. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053837A (en) * 1958-10-01 1962-09-11 Olin Mathieson 16, 17-acetal and ketal derivatives of 6alpha, 12alpha-dihalo-16alpha, 17alpha-dihydroxy steroids of the pregnane series; and intermediates therefor
GB1179547A (en) * 1965-12-22 1970-01-28 Squibb & Sons Inc 01beta,12beta-Oxido-16alpha-Methyl-Pregnenes

Also Published As

Publication number Publication date
ATA504777A (de) 1979-08-15
DE2632678A1 (de) 1978-01-26
GB1589585A (en) 1981-05-13
LU77768A1 (enExample) 1977-10-17
NL7707920A (nl) 1978-01-18
FR2358421A1 (fr) 1978-02-10
JPS5315361A (en) 1978-02-13
BE856862A (fr) 1978-01-16
DK323877A (da) 1978-01-17
CH627191A5 (en) 1981-12-31
IT1125789B (it) 1986-05-14
FR2358421B1 (enExample) 1979-05-11
DE2632678C2 (de) 1986-02-27

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT359220B (de) Verfahren zur herstellung von neuen pregnan- derivaten
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT353987B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT360037B (de) Verfahren zur herstellung von neuen substi- tuierten phenylguanidinen
AT355743B (de) Verfahren zur herstellung von neuen kortikoiden
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT364367B (de) Verfahren zur herstellung von neuen oxepinen
AT355039B (de) Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen
AT355210B (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen
ATA570079A (de) Verfahren zur herstellung von neuen d-homosteroiden
ATA57779A (de) Verfahren zur herstellung von neuen 1-oxa- dethiacephalosporinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee